toronto dominion bank grew its position in shares of Mylan N.V. (NASDAQ:MYL) by 28.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 200,017 shares of the company’s stock after buying an additional 43,943 shares during the quarter. Toronto Dominion Bank’s holdings in Mylan were worth $6,274,000 as of its most recent filing with the SEC.
Other institutional investors have also recently made changes to their positions in the company. pzena investment management llc grew its stake in Mylan by 84.1% in the 3rd quarter. Pzena Investment Management LLC now owns 22,721,384 shares of the company’s stock valued at $712,770,000 after acquiring an additional 10,381,697 shares during the last quarter. vanguard group inc. boosted its stake in shares of Mylan by 12.0% during the 2nd quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after purchasing an additional 3,531,974 shares during the last quarter. Mivtachim The workers social insurance fund ltd. Under Special Management acquired a new stake in shares of Mylan during the 2nd quarter worth about $84,364,000. BlackRock Inc. boosted its stake in shares of Mylan by 4.5% during the 2nd quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock worth $1,575,089,000 after purchasing an additional 1,751,515 shares during the last quarter. Finally, schroder investment management group boosted its stake in shares of Mylan by 161,445.9% during the 2nd quarter. Schroder Investment Management Group now owns 1,731,772 shares of the company’s stock worth $67,124,000 after purchasing an additional 1,730,700 shares during the last quarter. Institutional investors own 73.86% of the company’s stock.
Shares of Mylan N.V. (NASDAQ MYL) traded up $1.59 on Friday, hitting $38.12. 7,798,740 shares of the stock traded hands, compared to its average volume of 4,753,976. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87. The firm has a market capitalization of $20,448.94, a P/E ratio of 8.11, a price-to-earnings-growth ratio of 2.09 and a beta of 1.39. The company has a current ratio of 1.46, a quick ratio of 0.95 and a debt-to-equity ratio of 1.05.
Mylan (NASDAQ:MYL) last issued its quarterly earnings data on Monday, November 6th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.10). Mylan had a net margin of 7.28% and a return on equity of 20.63%. The company had revenue of $2.99 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter in the prior year, the firm earned $1.38 earnings per share. Mylan’s revenue for the quarter was down 2.3% compared to the same quarter last year. equities analysts expect that Mylan N.V. will post 4.56 EPS for the current fiscal year.
several research firms have issued reports on MYL. Cowen reaffirmed a “hold” rating and set a $30.00 price target (down from $43.00) on shares of Mylan in a research note on Wednesday, August 9th. Cantor Fitzgerald set a $34.00 target price on shares of Mylan and gave the stock a “hold” rating in a research report on Wednesday, August 9th. Wells Fargo & Company set a $30.00 target price on shares of Mylan and gave the stock a “hold” rating in a research report on Wednesday, August 9th. Royal Bank Of Canada restated a “sector perform” rating and issued a $32.00 price target (down previously from $33.00) on shares of Mylan in a report on Thursday, August 10th. Finally, bmo capital markets restated an “outperform” rating and issued a $45.00 price target (down previously from $50.00) on shares of Mylan in a report on Thursday, August 10th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $41.49.
TRADEMARK VIOLATION NOTICE: “Mylan N.V. (MYL) Holdings Increased by Toronto Dominion Bank” was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://ledgergazette.com/2017/12/04/toronto-dominion-bank-acquires-43943-shares-of-mylan-n-v-myl.html.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Mylan N.V. and related companies with MarketBeat.com’s FREE daily email newsletter.